Safety, Tolerability, and Immunogenicity of VAL-339851 in Healthy Adult Subjects

NCT03345043 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
156
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

ModernaTX, Inc.